Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-activity studies with histamine H3-receptor ligands

C R Ganellin1, A Fkyerat, S K Hosseini

  • 1Department of Chemistry, Christopher Ingold Laboratories, University College, London, UK.

Journal De Pharmacie De Belgique
|March 1, 1995
PubMed
Summary

Researchers synthesized novel histamine H3 receptor antagonists, moving beyond thioperamide. New compounds show potent activity and improved brain penetration, offering potential therapeutic advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pharmacology of cimetidine, a new histamine H2-receptor antagonist. 1975.

British journal of pharmacology·2010
Same author

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology.

The Journal of pharmacology and experimental therapeutics·2006
Same author

Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.

Die Pharmazie·2005
Same author

Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor.

Journal of neural transmission. Supplementum·2003
Same author

Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.

Die Pharmazie·2002
Same author

The histamine H3 receptor and its ligands.

Progress in medicinal chemistry·2002

Area of Science:

  • Medicinal Chemistry
  • Neuropharmacology
  • Histamine Receptor Research

Background:

  • Thioperamide was the first potent and selective histamine H3-receptor antagonist.
  • Developing new H3 receptor antagonists with improved properties is a key research area.

Purpose of the Study:

  • To synthesize and test analogues of thioperamide to explore structure-activity relationships.
  • To design compounds without the thiourea group for potentially enhanced brain penetration.
  • To identify potent H3 receptor antagonists with potential therapeutic applications.

Main Methods:

  • In vitro testing of synthesized analogues on rat cerebral cortex.
  • Structure-activity relationship (SAR) studies.
  • Synthesis of novel imidazole derivatives and isothioureas.

Related Experiment Videos

Main Results:

  • Compounds derived from histamine with aromatic nitrogen-containing heterocycles exhibited strong H3 antagonist activity.
  • Aryloxyethyl- and aryloxy-propylimidazoles were identified as potent H3 antagonists.
  • Structure-activity studies revealed potent agonists and antagonists, including N,N'-Dibutyl-[S-[3-(imidazol-4-yl)propyl]isothiourea with Ki = 1.5 nM.

Conclusions:

  • Novel H3 receptor antagonists have been successfully designed and synthesized.
  • The developed compounds demonstrate potent H3 antagonist activity and potential for improved brain penetration.
  • These findings contribute to the development of new therapeutic agents targeting the H3 receptor.